1. Home
  2. ISTR vs CRVS Comparison

ISTR vs CRVS Comparison

Compare ISTR & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Investar Holding Corporation

ISTR

Investar Holding Corporation

HOLD

Current Price

$26.25

Market Cap

268.9M

Sector

Finance

ML Signal

HOLD

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$7.30

Market Cap

546.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ISTR
CRVS
Founded
2006
2014
Country
United States
United States
Employees
N/A
31
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
268.9M
546.7M
IPO Year
2014
2016

Fundamental Metrics

Financial Performance
Metric
ISTR
CRVS
Price
$26.25
$7.30
Analyst Decision
Buy
Strong Buy
Analyst Count
1
4
Target Price
$29.00
$13.75
AVG Volume (30 Days)
49.9K
1.6M
Earning Date
01-22-2026
11-04-2025
Dividend Yield
1.65%
N/A
EPS Growth
24.14
N/A
EPS
2.22
N/A
Revenue
$93,426,000.00
N/A
Revenue This Year
$7.18
N/A
Revenue Next Year
$70.45
N/A
P/E Ratio
$11.79
N/A
Revenue Growth
12.93
N/A
52 Week Low
$15.39
$2.54
52 Week High
$27.95
$9.60

Technical Indicators

Market Signals
Indicator
ISTR
CRVS
Relative Strength Index (RSI) 48.30 39.32
Support Level $27.04 $7.28
Resistance Level $27.64 $7.86
Average True Range (ATR) 0.46 0.44
MACD -0.21 -0.07
Stochastic Oscillator 5.03 10.00

Price Performance

Historical Comparison
ISTR
CRVS

About ISTR Investar Holding Corporation

Investar Holding Corp is a U.S.-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashiers' checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

Share on Social Networks: